Huntsworth plc

HNT

GB00B0CRWK29

Advertising & Marketing

Delayed London S.E. Other stock markets 16:35:21 30/04/2020 BST			5-day change	1st Jan Change
107.5 ^GBX	-.--%		-.--%	+32.06%

2022	Huntsworth Limited acquired The Cirkle Partnership Limited.	CI
2020	Huntsworth Limited announced that it has received funding from Clayton, Dubilier & Rice, LLC	CI

Huntsworth plc Announces Executive Changes, Effective April 7, 2015

February 12, 2015 at 11:04 am

The Board of Huntsworth plc confirmed that Paul Taaffe will be appointed as Chief Executive on April 7, 2015. Paul Taaffe succeeds Lord Chadlington, who will stand down from the Huntsworth Board on the same date.

Latest news about Huntsworth plc

Huntsworth Limited acquired The Cirkle Partnership Limited.	06/04/22	CI
Huntsworth Limited announced that it has received funding from Clayton, Dubilier & Rice, LLC	30/12/20	CI
Huntsworth plc completed the acquisition of Nucleus Global Limited.	10/12/20	CI
Huntsworth plc entered into an agreement to acquire Nucleus Global Limited.	05/11/20	CI
Nicky Dulieu Step Down as Non-Executive Director of Huntsworth plc	01/05/20	CI
Huntsworth plc(LSE:HNT) dropped from FTSE All-Small Index	01/05/20	CI
Huntsworth plc(LSE:HNT) dropped from FTSE All-Share Index	01/05/20	CI
Clayton, Dubilier & Rice Fund X, L.P., Clayton, Dubilier & Rice Fund X-A, L.P., CD&R Advisor Fund X, L.P., funds managed by Clayton, Dubilier & Rice, LLC completed the acquisition of Huntsworth plc from Aberforth Partners LLP, Kabouter Management L.L.C., Kames Capital plc, Merian Global Investors (UK) Limited, Hargreave Hale Limited and others.	30/04/20	CI
Huntsworth plc Proposes Final Dividend, Payable on September 18, 2020	09/04/20	CI
Huntsworth : U.S. buyout firm CD&R to buy UK's Huntsworth for £400 million in pharma bet	03/03/20	RE
Huntsworth plc Propose Final Dividend for the Year Ended 31 December 2019, Payable on 6 July 2020	03/03/20	CI
Huntsworth plc Reports Earnings Results for the Full Year Ended December 31, 2019	03/03/20	CI
Clayton, Dubilier & Rice Fund X, L.P., Clayton, Dubilier & Rice Fund X-A, L.P., CD&R Advisor Fund X, L.P. funds managed by Clayton, Dubilier & Rice, LLC reached an agreement to acquire Huntsworth plc from Aberforth Partners LLP, Kabouter Management L.L.C., Kames Capital plc, Merian Global Investors (UK) Limited, Hargreave Hale Limited and others for approximately £400 million.	02/03/20	CI
Huntsworth plc Provides Revenue Guidance for the Year Ending December 31, 2019	17/12/19	CI
A selection of British stocks to play the Brexit game	16/10/19
Huntsworth plc Announces Board Changes	01/10/19	CI
Loretta Ahmed, Chief Executive Officer of Grayling Communications Limited acquired Grayling Communications Limited from Huntsworth plc.	11/09/19	CI
Huntsworth plc Announces Dividend for the First Half of 2019, Payable on November 6, 2019; Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2019	23/07/19	CI
Huntsworth PLC Appoints Helen Apostolidis as Chief Talent Officer	17/07/19	CI
Huntsworth plc acquired 70% stake in Creativ Ceutical S.À R.L. from Avicenne Invest S.A.	20/05/19	CI
Huntsworth plc acquired an 85% stake in Kyne Communications LLC and Kyne Communications Limited from David Kyne, his wife Jacqueline Kyne, and their associates for $17.4 million.	20/05/19	CI
Transcript : Huntsworth plc - Analyst/Investor Day	09/05/19
Huntsworth plc Announces Directorate Changes	06/03/19	CI
Huntsworth plc Proposes Final Dividend, Payable on July 4, 2019	05/03/19	CI
Huntsworth plc Reports Audited Preliminary Consolidated Earnings Results for the Year Ended December 31, 2018; Provides Earnings Guidance for the Fiscal Year 2019	05/03/19	CI

Chart Huntsworth plc

Duration

Period

More charts

Company Profile

Huntsworth Limited is a United Kingdom-based intermediate holding company. The Company is engaged in healthcare and communication activities. The Company, through its subsidiaries, is focused on health that provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceuticals and biotechnology companies. It also provides a range of communications and advisory services, including strategic communications, public affairs, investor relations and consumer marketing. The Companyâs financial instruments comprise bank loans, bank overdrafts, loan notes, and cash and short-term deposits. The Companyâs geographical areas include the United Kingdom, Europe, the United States and the rest of the world. The Companyâs subsidiaries operate in approximately 28 in the United Kingdom and Europe.

Sector

Advertising & Marketing

More about the company

Sector Other Advertising & Marketing

	1st Jan change	Capi.
HUNTSWORTH PLC	+32.06%	508M
PUBLICIS GROUPE SA	+27.38%	28.96B
OMNICOM GROUP., INC.	+8.91%	18.45B
FOCUS MEDIA INFORMATION TECHNOLOGY CO., LTD.	+5.38%	13.28B
THE INTERPUBLIC GROUP OF COMPANIES, INC.	-3.80%	11.85B
WPP PLC	+9.16%	11.21B
JCDECAUX SE	+15.93%	4.87B
PEOPLE.CN CO., LTD	-18.37%	3.49B
AUTOHOME INC.	-3.81%	3.27B
CYBERAGENT, INC.	+13.89%	3.3B

Other Advertising & Marketing

Huntsworth plc

Equities

HNT

GB00B0CRWK29

Advertising & Marketing

Huntsworth plc Announces Executive Changes, Effective April 7, 2015

Latest news about Huntsworth plc

Chart Huntsworth plc

Company Profile

Sector Other Advertising & Marketing